AVANTOR INC (AVTR) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:AVTR - US05352A1007 - Common Stock
11.34 USD
+0.07 (+0.62%)
Taking everything into account, AVTR scores 4 out of 10 in our fundamental rating. AVTR was compared to 57 industry peers in the Life Sciences Tools & Services industry. There are concerns on the financial health of AVTR while its profitability can be described as average. AVTR is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
AVTR had positive earnings in the past year.
AVTR had a positive operating cash flow in the past year.
AVTR had positive earnings in each of the past 5 years.
In the past 5 years AVTR always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.70%, AVTR is in the better half of the industry, outperforming 61.40% of the companies in the same industry.
AVTR has a Return On Equity of -1.48%. This is in the better half of the industry: AVTR outperforms 61.40% of its industry peers.
The Return On Invested Capital of AVTR (4.80%) is better than 70.18% of its industry peers.
AVTR had an Average Return On Invested Capital over the past 3 years of 6.58%. This is significantly below the industry average of 13.99%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.7% | ||
| ROE | -1.48% | ||
| ROIC | 4.8% |
ROA(3y)4.42%
ROA(5y)3.49%
ROE(3y)10.57%
ROE(5y)9.15%
ROIC(3y)6.58%
ROIC(5y)6.55%
1.3 Margins
AVTR's Profit Margin has improved in the last couple of years.
AVTR has a better Operating Margin (9.18%) than 68.42% of its industry peers.
AVTR's Operating Margin has improved in the last couple of years.
The Gross Margin of AVTR (33.13%) is worse than 64.91% of its industry peers.
In the last couple of years the Gross Margin of AVTR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.18% | ||
| PM (TTM) | N/A | ||
| GM | 33.13% |
OM growth 3Y-7.05%
OM growth 5Y2.19%
PM growth 3Y15.1%
PM growth 5YN/A
GM growth 3Y-0.28%
GM growth 5Y1.11%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AVTR is destroying value.
Compared to 1 year ago, AVTR has more shares outstanding
AVTR has more shares outstanding than it did 5 years ago.
AVTR has a better debt/assets ratio than last year.
2.2 Solvency
AVTR has an Altman-Z score of 1.76. This is a bad value and indicates that AVTR is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.76, AVTR perfoms like the industry average, outperforming 45.61% of the companies in the same industry.
AVTR has a debt to FCF ratio of 7.37. This is a slightly negative value and a sign of low solvency as AVTR would need 7.37 years to pay back of all of its debts.
AVTR's Debt to FCF ratio of 7.37 is fine compared to the rest of the industry. AVTR outperforms 61.40% of its industry peers.
A Debt/Equity ratio of 0.65 indicates that AVTR is somewhat dependend on debt financing.
The Debt to Equity ratio of AVTR (0.65) is worse than 73.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 7.37 | ||
| Altman-Z | 1.76 |
ROIC/WACC0.47
WACC10.13%
2.3 Liquidity
AVTR has a Current Ratio of 1.49. This is a normal value and indicates that AVTR is financially healthy and should not expect problems in meeting its short term obligations.
AVTR has a worse Current ratio (1.49) than 77.19% of its industry peers.
AVTR has a Quick Ratio of 1.49. This is a bad value and indicates that AVTR is not financially healthy enough and could expect problems in meeting its short term obligations.
AVTR has a worse Quick ratio (0.96) than 82.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.49 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
The earnings per share for AVTR have decreased by -2.04% in the last year.
Measured over the past years, AVTR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.82% on average per year.
The Revenue has decreased by -3.59% in the past year.
AVTR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.35% yearly.
EPS 1Y (TTM)-2.04%
EPS 3Y-10.82%
EPS 5YN/A
EPS Q2Q%-15.38%
Revenue 1Y (TTM)-3.59%
Revenue growth 3Y-2.8%
Revenue growth 5Y2.35%
Sales Q2Q%-5.28%
3.2 Future
Based on estimates for the next years, AVTR will show a small growth in Earnings Per Share. The EPS will grow by 5.40% on average per year.
The Revenue is expected to grow by 1.67% on average over the next years.
EPS Next Y-8.14%
EPS Next 2Y-3.98%
EPS Next 3Y1.33%
EPS Next 5Y5.4%
Revenue Next Year-4.16%
Revenue Next 2Y-2.02%
Revenue Next 3Y-0.12%
Revenue Next 5Y1.67%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
AVTR is valuated reasonably with a Price/Earnings ratio of 11.81.
Compared to the rest of the industry, the Price/Earnings ratio of AVTR indicates a rather cheap valuation: AVTR is cheaper than 98.25% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.39. AVTR is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 12.30, which indicates a correct valuation of AVTR.
98.25% of the companies in the same industry are more expensive than AVTR, based on the Price/Forward Earnings ratio.
AVTR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.84, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.81 | ||
| Fwd PE | 12.3 |
4.2 Price Multiples
AVTR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AVTR is cheaper than 96.49% of the companies in the same industry.
92.98% of the companies in the same industry are more expensive than AVTR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.77 | ||
| EV/EBITDA | 11.16 |
4.3 Compensation for Growth
The decent profitability rating of AVTR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.98%
EPS Next 3Y1.33%
5. Dividend
5.1 Amount
AVTR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NYSE:AVTR (12/22/2025, 9:35:01 AM)
11.34
+0.07 (+0.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners100.14%
Inst Owner Change-5.15%
Ins Owners0.3%
Ins Owner Change6.24%
Market Cap7.73B
Revenue(TTM)6.58B
Net Income(TTM)-82.20M
Analysts70.77
Price Target13.84 (22.05%)
Short Float %4.57%
Short Ratio2.8
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.53%
Min EPS beat(2)-5.09%
Max EPS beat(2)-3.97%
EPS beat(4)1
Avg EPS beat(4)-2.12%
Min EPS beat(4)-5.09%
Max EPS beat(4)2.94%
EPS beat(8)5
Avg EPS beat(8)1.74%
EPS beat(12)6
Avg EPS beat(12)0.63%
EPS beat(16)9
Avg EPS beat(16)1.07%
Revenue beat(2)0
Avg Revenue beat(2)-2.39%
Min Revenue beat(2)-3.35%
Max Revenue beat(2)-1.44%
Revenue beat(4)0
Avg Revenue beat(4)-2.91%
Min Revenue beat(4)-3.57%
Max Revenue beat(4)-1.44%
Revenue beat(8)0
Avg Revenue beat(8)-2.36%
Revenue beat(12)0
Avg Revenue beat(12)-2.35%
Revenue beat(16)0
Avg Revenue beat(16)-2.39%
PT rev (1m)-5.85%
PT rev (3m)-3.12%
EPS NQ rev (1m)0.2%
EPS NQ rev (3m)-15.13%
EPS NY rev (1m)-1.09%
EPS NY rev (3m)-4.91%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)-3.97%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-1.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.81 | ||
| Fwd PE | 12.3 | ||
| P/S | 1.18 | ||
| P/FCF | 14.77 | ||
| P/OCF | 12 | ||
| P/B | 1.39 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.16 |
EPS(TTM)0.96
EY8.47%
EPS(NY)0.92
Fwd EY8.13%
FCF(TTM)0.77
FCFY6.77%
OCF(TTM)0.95
OCFY8.33%
SpS9.64
BVpS8.17
TBVpS-3.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number13.28
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.7% | ||
| ROE | -1.48% | ||
| ROCE | 5.94% | ||
| ROIC | 4.8% | ||
| ROICexc | 4.92% | ||
| ROICexgc | 29.45% | ||
| OM | 9.18% | ||
| PM (TTM) | N/A | ||
| GM | 33.13% | ||
| FCFM | 7.96% |
ROA(3y)4.42%
ROA(5y)3.49%
ROE(3y)10.57%
ROE(5y)9.15%
ROIC(3y)6.58%
ROIC(5y)6.55%
ROICexc(3y)6.76%
ROICexc(5y)6.74%
ROICexgc(3y)52.77%
ROICexgc(5y)49.06%
ROCE(3y)8.14%
ROCE(5y)8.11%
ROICexgc growth 3Y9.06%
ROICexgc growth 5Y15.03%
ROICexc growth 3Y-3.1%
ROICexc growth 5Y1.59%
OM growth 3Y-7.05%
OM growth 5Y2.19%
PM growth 3Y15.1%
PM growth 5YN/A
GM growth 3Y-0.28%
GM growth 5Y1.11%
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 7.37 | ||
| Debt/EBITDA | 3.6 | ||
| Cap/Depr | 29.62% | ||
| Cap/Sales | 1.84% | ||
| Interest Coverage | 3.73 | ||
| Cash Conversion | 63.69% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.49 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 1.76 |
F-Score5
WACC10.13%
ROIC/WACC0.47
Cap/Depr(3y)35.33%
Cap/Depr(5y)30.17%
Cap/Sales(3y)2.02%
Cap/Sales(5y)1.71%
Profit Quality(3y)143.28%
Profit Quality(5y)453.06%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.04%
EPS 3Y-10.82%
EPS 5YN/A
EPS Q2Q%-15.38%
EPS Next Y-8.14%
EPS Next 2Y-3.98%
EPS Next 3Y1.33%
EPS Next 5Y5.4%
Revenue 1Y (TTM)-3.59%
Revenue growth 3Y-2.8%
Revenue growth 5Y2.35%
Sales Q2Q%-5.28%
Revenue Next Year-4.16%
Revenue Next 2Y-2.02%
Revenue Next 3Y-0.12%
Revenue Next 5Y1.67%
EBIT growth 1Y-4.14%
EBIT growth 3Y-9.65%
EBIT growth 5Y4.59%
EBIT Next Year2.52%
EBIT Next 3Y1.39%
EBIT Next 5Y3.54%
FCF growth 1Y-24.62%
FCF growth 3Y-6.35%
FCF growth 5Y18.01%
OCF growth 1Y-21.8%
OCF growth 3Y-4.11%
OCF growth 5Y18.89%
AVANTOR INC / AVTR FAQ
What is the ChartMill fundamental rating of AVANTOR INC (AVTR) stock?
ChartMill assigns a fundamental rating of 4 / 10 to AVTR.
Can you provide the valuation status for AVANTOR INC?
ChartMill assigns a valuation rating of 7 / 10 to AVANTOR INC (AVTR). This can be considered as Undervalued.
How profitable is AVANTOR INC (AVTR) stock?
AVANTOR INC (AVTR) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for AVTR stock?
The Price/Earnings (PE) ratio for AVANTOR INC (AVTR) is 11.81 and the Price/Book (PB) ratio is 1.39.
Can you provide the financial health for AVTR stock?
The financial health rating of AVANTOR INC (AVTR) is 2 / 10.